FDA Inspection 1118357 — Marek Krogulec, MD
The FDA completed an inspection of Marek Krogulec, MD on January 23, 2020 in Nadarzyn. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nadarzyn (Poland)
Additional Details
Clinical Investigator (CI)